Broad Spectrum AI Designed Antibiotics for AMR
AINovo has used our proprietary AI platform to design novel biologic therapeutics which show broad-spectrum activity against clinical strains of AMR pathogens.
AI-designed molecules show broad spectrum activity for AMR Pathogens in vitro, synergy with existing antibiotics, variety of formulations possible
- Antimicrobial compound/strategy
- License, Co-develop
- OTHER / NA
Infectious disease area:
- North America
AINovo has developed a proprietary artificial intelligence platform to design protein-based medicines &diagnostics for oncology & infectious diseases.
Partnerships with biopharma and research institutions for further development of our AMR assets, Technology-based partnerships with biopharma for joint development of novel molecules through AINovo Biotech’s artificial intelligence platform